Host: UM BioPark & Wexford + Technology
Location: UM BioPark Life Sciences Conference Center, 801 W. Baltimore Street, Baltimore, Maryland 21201
Date: March 30, 2017 – 5:00pm to 6:30pm
Please join the BioPark’s Monthly Networking Event along with collegues from the Maryland Proton Treatment Center. Mingle with MPTC leadership and staff, BioPark tenants, and UMB faculty and staff.
The co-founders of a Johns Hopkins-backed startup had personal motivations for developing better health care tracking technology.
The mother of Sathya Elumala, who is CEO of Multisensor Diagnostics, suffers from multiple chronic health conditions and spends time in hospitals almost every month. Gene Fridman, the company’s chief technology officer, lost a sister who had a chronic condition that wasn’t detected soon enough.
Vaccines may be available for pneumococcal infections, but none of them, including the widely used Prevnar 13, can cover all strains. SutroVax is one of the startups trying to solve that problem, and today raised $64 million to test its approach in humans.
New investors Frazier Healthcare Partners and Pivotal bioVenture Partners led the Series B financing round for Foster City, CA-based SutroVax. Also participating in the round were earlier investors Abingworth, Longitude Capital, Roche Venture Fund, and CTI Life Sciences Fund. In addition to the $60 million Series B investment, SutroVax says the earlier investors are also putting another $4 million into the company.
The National Science Foundation’s Small Business Innovation Research (SBIR) program provides small business with equity-free funding to conduct research and development (R&D) work and de-risk technology for commercial success. The NSF SBIR program accepts innovative proposals that show promise of commercial and societal impact in almost all areas of technology.
SBIR Phase I proposals are expected to undertake R&D with the aim of establishing technical feasibility or proof of concept. Successful applicants will receive a grant of up to $225,000 over a period of 6 to 12 months (the period to be decided by the company).
Successful SBIR proposers will receive funding about 6 months after the solicitation deadline. Companies that receive a Phase I award are eligible to apply for a Phase II award (award amount up to $750,000; duration 2 years).
In order for America to maintain its innovative and technological competitive advantage, it is imperative that current policy design favor high growth formation through the catalytic means of institutional financing. The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs have historically served as crucial financing to help de-risk early-stage technology development and enable validation that encourages follow-on private institution capitalization. With new trends in the Internet of Things, artificial intelligence, advanced materials, genomics, environmental sustainability, renewable energy, national security, and many other areas evolving over the years ahead, national governments bear the responsibility for helping seed the inventive fire that enables economic growth as we move forward.
WEDNESDAY, APRIL 19, 2017, 8:30 AM – 12 PM | WASHINGTON, DC
If you do business with the government, you are a target for cyber-attacks!
If you are a government contractor, join us to learn how to implement a strong and cost effective cybersecurity program that will strengthen your company’s cybersecurity posture and help you meet requirements necessary to do business with the federal government. As an attendee, you can receive two customized assessments to help identify your company’s level of exposure: (1) a mini cyber-risk review from CyberRx that will assess your company’s cyber capabilities within the Cybersecurity Framework; and (2) a threat intelligence assessment from Wapack Labs that can help to identify if your organization has been or will be the victim of an attack. Space is limited. Register today.
Pulmocide raised $30.4 million in a Series B round of financing to support the early clinical development of its lead inhaled drugs against respiratory syncytial virus (RSV) and pulmonary aspergillosis. The fundraising round was led by new investor SR One and included the Longwood Fund and existing investors SV Life Sciences, F-Prime Capital, Johnson & Johnson Innovation–JJDC, and Touchstone Innovations.
The National Cancer Institute has picked the Johns Hopkins Montgomery County Campus as the site for a new laboratory building for its epidemiology and genetics researchers.
The planned 70,000-square-foot building will bring together about 134 scientists and employees now working in separate facilities in Gaithersburg and Frederick, about 25 miles apart.
The University of Maryland University College is tearing itself apart — on purpose.
The university, which gets nearly all of its funding from tuition revenue, has long relied on enrolling large numbers of students associated with the military for financial stability. After teaching students at military bases across Asia and Europe for decades, the university was quick to realize the potential of the internet and became a pioneer in the field of distance education.
Friday, April 14, 2017 7:30 AM – 9:30 AM
Bethesda Marriott – 5151 Pooks Hill Road Bethesda, MD 20814
With the transition to the Trump administration, change is coming rapidly in the form of legislative proposals, regulations (or repeal thereof), and policy statements. How will all this affect the ability of tech companies to raise the capital they need to grow. Amid this shifting ground, we’ve asked an expert panel of our own Maryland technology companies to talk about their recent successes and challenges in raising capital and their outlook for the ability of Maryland technology companies to do the same. Our panel, moderated by David Straut of Wells Fargo, includes two long-time local tech CFOs who have had recent success raising money and the Director of the Maryland Venture Fund, which oversees investments in approximately 50 local technology ventures
Financial Executives Forum: FEF is devoted to peer-to-peer connections and programs that highlight the latest topics of interest for the region’s leading business and financial executives. FEF encourages participants to connect as well as learn from some of the area’s preeminent executives, policymakers and thought leaders.
